|
Dr. Ravi Pottathil is a recognized authority in the field HIV/AIDS diagnostics and therapeutics. In this regard Dr. Pottathil was the Section Manager for Retroviruses (focus on HIV and HCV) and Tumor markers and PCR diagnostics at Hoffman La Roche from 1985 to 1992. Upon completing his tenure at Roche Dr. Pottathil co-founded Specialty Biosystems Inc a venture of Specialty Labs one of the largest independent reference laboratories in California. Dr. Pottathil has also advised the World Health Organization's Sexually Transmitted Diseases and Global Vaccination Program.
Dr. Pottathil has worked with Dr. Robert Huebner of the NIH in immunology and virology at The Jackson Laboratory and with Drs. David Lang and Wolfgang Joklik at Duke University on interferons anti-tumor RNAs and antigenic suppression of tumorigenic retroviruses. Academic positions include: Assistant Professor at the University of Maryland School of Medicine; Associate Professor at the City of Hope Medical Center in Duarte California where he published extensively with Dr. Pedro Cuatrecasas (one of developers of affinity chromatography); and Adjunct Professor in Cellular and Molecular Biology at Down State Medical Center and Rutgers University.
As a virologist and molecular biologist Dr. Pottathil has over 40 refereed publications to his credit and has been a Director of OncQuest Inc. GeneQuest Inc. Specialty Laboratories Asia in Singapore and Specialty Ranbaxy in India. Currently Dr. Pottathil is the President of AccuDx Inc. a pharmaceutical diagnostics company he founded in 1996. | 